ÂÜŔňÂŇÂ×

Peter serves as the Chief Operating Officer at Mercia Asset Management PLC. He joined the Group in 2015 as Head of Life Sciences & Biosciences, with over 20 years’ experience in this sector. He is responsible for a number of the life science portfolio investments including Medovate, Concepta plc, Sense Biodetection and Axis Spine Technologies. Peter is also the Managing Director for the Mercia EIS and VCT fund management business within Mercia.

Peter has been involved with a number of turnarounds and exits within the sector, including the acquisition of Surgicraft’s loss-making business where, as Managing Director, sales quadrupled within three years and the business was subsequently sold to a private equity backed business and Diagnostic World, a fast-growing diagnostic provider to the NHS.